Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (201)	1/17/2007 2:33:37 PM
From: tuck	Respond to of 588

[Characterization of the Mas-related gene family: structural and functional conservation of human and rhesus MrgX receptors] This is now a full text freebie: nature.com Haven't seen much about ER-beta and pain, while PAR-2 seems to have many roles. If there are subtypes of ER-Beta & PAR-2 that are more selectively involved in pain, I haven't found the references. There's a boat load of folks working with those receptors (though not many looking at pain wrt ER-Beta), while research into the MrgX family is still limited. Reading tea leaves (not like the website waxes effusive about preclinical programs), I'd guess the MrgX program would be the most interesting to Acadia at this point. Might have to go hunting in the patent database to see if anything there points to a direction among the possibilities. Cheers, Tuck